MS Views and News Be empowered with MS views and news. To receive The MS BEACON e-Newsletter, CLICK HERE - -

Visit our MS learning channel on YouTube, which provides hundreds of MS educational videos presented by MS Experts from across the USA. Archived here: -- Also please visit our Social media platforms: Facebook, Twitter, and Instagram . Each providing important information for the MS community. Furthermore, scroll down the left side of this blog to learn from the resources and links.

Disclaimer: 'MS Views and News' DOES NOT endorse any products or services found on this blog. It is up to you to seek advice from your healthcare provider. The intent of this blog is to provide information on various medical conditions, medications, treatments, for your personal knowledge and to keep you informed of current health-related issues. It is not a substitute for the advice of your physician. Should you or your family members have any specific medical problem, seek medical care promptly.


Friday, April 30, 2010

Mouse DNA Stops Progression Of Multiple Sclerosis

A tiny creature could hold the key to stopping the progression of multiple sclerosis. DNA from a mouse is being infused into patients. It's FDA approved and patients are seeing results.

"I am not expecting a cure," said Violet Lotito, who suffers from MS. "I am just expecting some help."

Lotito loves being in the middle of the mix -- either substitute teaching or cutting and styling hair.

But recently she couldn't even stand, let alone work. Her MS got so bad, life wasn't fun.

"The benefit hasn't gone higher than the risk until now," said Lotito. "Now that my symptoms have increased it is time to do something."

Lotito turned to infusions of a drug called tysabri -- a monoclonal antibody that contains DNA from a mouse and a human.

"Monoclonal antibodies are designed in the lab and they are specifically targeted toward specific molecules on white blood cells," said Dr. John Corboy, of University of Colorado Hospital.

"Providing You with 'MS Views and News', is What We Do"



No comments: